Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins

Cannabidiol (CBD), one of the most abundant Cannabis sativa -derived compounds, has been implicated with neuroprotective effect in several human pathologies. Until now, no undesired side effects have been associated with CBD. In this study, we evaluated CBD’s neuroprotective effect in terminal diffe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular neurobiology 2015-08, Vol.52 (1), p.26-37
Hauptverfasser: Schönhofen, Patrícia, de Medeiros, Liana M., Bristot, Ivi Juliana, Lopes, Fernanda M., De Bastiani, Marco A., Kapczinski, Flávio, Crippa, José Alexandre S., Castro, Mauro Antônio A., Parsons, Richard B., Klamt, Fábio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 37
container_issue 1
container_start_page 26
container_title Molecular neurobiology
container_volume 52
creator Schönhofen, Patrícia
de Medeiros, Liana M.
Bristot, Ivi Juliana
Lopes, Fernanda M.
De Bastiani, Marco A.
Kapczinski, Flávio
Crippa, José Alexandre S.
Castro, Mauro Antônio A.
Parsons, Richard B.
Klamt, Fábio
description Cannabidiol (CBD), one of the most abundant Cannabis sativa -derived compounds, has been implicated with neuroprotective effect in several human pathologies. Until now, no undesired side effects have been associated with CBD. In this study, we evaluated CBD’s neuroprotective effect in terminal differentiation (mature) and during neuronal differentiation (neuronal developmental toxicity model) of the human neuroblastoma SH-SY5Y cell line. A dose-response curve was performed to establish a sublethal dose of CBD with antioxidant activity (2.5 μM). In terminally differentiated SH-SY5Y cells, incubation with 2.5 μM CBD was unable to protect cells against the neurotoxic effect of glycolaldehyde, methylglyoxal, 6-hydroxydopamine, and hydrogen peroxide (H 2 O 2 ). Moreover, no difference in antioxidant potential and neurite density was observed. When SH-SY5Y cells undergoing neuronal differentiation were exposed to CBD, no differences in antioxidant potential and neurite density were observed. However, CBD potentiated the neurotoxicity induced by all redox-active drugs tested. Our data indicate that 2.5 μM of CBD, the higher dose tolerated by differentiated SH-SY5Y neuronal cells, does not provide neuroprotection for terminally differentiated cells and shows, for the first time, that exposure of CBD during neuronal differentiation could sensitize immature cells to future challenges with neurotoxins.
doi_str_mv 10.1007/s12035-014-8843-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1709190243</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1709190243</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-249de32fce4a293310f1d5b324e64211721e3b59510d29bf48134ddec7c963503</originalsourceid><addsrcrecordid>eNp1kUtv1DAUhS3Uik5LfwAbFKmbbgy-fsTxcjQtFKmiEtC15SQ3lauMPdhJNeXX41EKQkis7uJ-59zHIeQtsPfAmP6QgTOhKANJm0YKCq_ICpQyFKDhR2TFGiOormVzQk5zfmSMc2D6NTnhClhTa7Yiw8aF4Frf-zhW1_tdzHPC6mpOPjxUX3BOMbixuvLDgAnD5N3kY6i-Ych-8j8xVxscx1ytH5wPeaq-Yh_3dN1N_gkX-RT3pfOGHA9uzHj-Us_I_cfr75sbenv36fNmfUs7JWGiXJoeBR86lI4bIYAN0KtWcIm15ACaA4pWmbJ-z007yAaE7HvsdGdqoZg4I5eL7y7FHzPmyW597sqKLmCcswXNDBjGpSjoxT_oY5xTubZQtdEapDKyULBQXYo5JxzsLvmtS88WmD2EYJcQbAnBHkKwUDTvXpzndov9H8XvrxeAL0DeHf6M6a_R_3X9BSd6kY0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1697714594</pqid></control><display><type>article</type><title>Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins</title><source>MEDLINE</source><source>SpringerLink</source><creator>Schönhofen, Patrícia ; de Medeiros, Liana M. ; Bristot, Ivi Juliana ; Lopes, Fernanda M. ; De Bastiani, Marco A. ; Kapczinski, Flávio ; Crippa, José Alexandre S. ; Castro, Mauro Antônio A. ; Parsons, Richard B. ; Klamt, Fábio</creator><creatorcontrib>Schönhofen, Patrícia ; de Medeiros, Liana M. ; Bristot, Ivi Juliana ; Lopes, Fernanda M. ; De Bastiani, Marco A. ; Kapczinski, Flávio ; Crippa, José Alexandre S. ; Castro, Mauro Antônio A. ; Parsons, Richard B. ; Klamt, Fábio</creatorcontrib><description>Cannabidiol (CBD), one of the most abundant Cannabis sativa -derived compounds, has been implicated with neuroprotective effect in several human pathologies. Until now, no undesired side effects have been associated with CBD. In this study, we evaluated CBD’s neuroprotective effect in terminal differentiation (mature) and during neuronal differentiation (neuronal developmental toxicity model) of the human neuroblastoma SH-SY5Y cell line. A dose-response curve was performed to establish a sublethal dose of CBD with antioxidant activity (2.5 μM). In terminally differentiated SH-SY5Y cells, incubation with 2.5 μM CBD was unable to protect cells against the neurotoxic effect of glycolaldehyde, methylglyoxal, 6-hydroxydopamine, and hydrogen peroxide (H 2 O 2 ). Moreover, no difference in antioxidant potential and neurite density was observed. When SH-SY5Y cells undergoing neuronal differentiation were exposed to CBD, no differences in antioxidant potential and neurite density were observed. However, CBD potentiated the neurotoxicity induced by all redox-active drugs tested. Our data indicate that 2.5 μM of CBD, the higher dose tolerated by differentiated SH-SY5Y neuronal cells, does not provide neuroprotection for terminally differentiated cells and shows, for the first time, that exposure of CBD during neuronal differentiation could sensitize immature cells to future challenges with neurotoxins.</description><identifier>ISSN: 0893-7648</identifier><identifier>EISSN: 1559-1182</identifier><identifier>DOI: 10.1007/s12035-014-8843-1</identifier><identifier>PMID: 25108670</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Cannabidiol - chemistry ; Cannabidiol - pharmacology ; Cell Biology ; Cell Differentiation - drug effects ; Cell Line, Tumor ; Cell Shape - drug effects ; Cells ; Gene Expression Regulation - drug effects ; Humans ; Neurobiology ; Neurology ; Neurons - cytology ; Neurons - drug effects ; Neurosciences ; Neurotoxicity ; Neurotoxins - toxicity ; Oxidation-Reduction - drug effects ; Tretinoin - pharmacology</subject><ispartof>Molecular neurobiology, 2015-08, Vol.52 (1), p.26-37</ispartof><rights>Springer Science+Business Media New York 2014</rights><rights>Springer Science+Business Media New York 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-249de32fce4a293310f1d5b324e64211721e3b59510d29bf48134ddec7c963503</citedby><cites>FETCH-LOGICAL-c541t-249de32fce4a293310f1d5b324e64211721e3b59510d29bf48134ddec7c963503</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12035-014-8843-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12035-014-8843-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25108670$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schönhofen, Patrícia</creatorcontrib><creatorcontrib>de Medeiros, Liana M.</creatorcontrib><creatorcontrib>Bristot, Ivi Juliana</creatorcontrib><creatorcontrib>Lopes, Fernanda M.</creatorcontrib><creatorcontrib>De Bastiani, Marco A.</creatorcontrib><creatorcontrib>Kapczinski, Flávio</creatorcontrib><creatorcontrib>Crippa, José Alexandre S.</creatorcontrib><creatorcontrib>Castro, Mauro Antônio A.</creatorcontrib><creatorcontrib>Parsons, Richard B.</creatorcontrib><creatorcontrib>Klamt, Fábio</creatorcontrib><title>Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins</title><title>Molecular neurobiology</title><addtitle>Mol Neurobiol</addtitle><addtitle>Mol Neurobiol</addtitle><description>Cannabidiol (CBD), one of the most abundant Cannabis sativa -derived compounds, has been implicated with neuroprotective effect in several human pathologies. Until now, no undesired side effects have been associated with CBD. In this study, we evaluated CBD’s neuroprotective effect in terminal differentiation (mature) and during neuronal differentiation (neuronal developmental toxicity model) of the human neuroblastoma SH-SY5Y cell line. A dose-response curve was performed to establish a sublethal dose of CBD with antioxidant activity (2.5 μM). In terminally differentiated SH-SY5Y cells, incubation with 2.5 μM CBD was unable to protect cells against the neurotoxic effect of glycolaldehyde, methylglyoxal, 6-hydroxydopamine, and hydrogen peroxide (H 2 O 2 ). Moreover, no difference in antioxidant potential and neurite density was observed. When SH-SY5Y cells undergoing neuronal differentiation were exposed to CBD, no differences in antioxidant potential and neurite density were observed. However, CBD potentiated the neurotoxicity induced by all redox-active drugs tested. Our data indicate that 2.5 μM of CBD, the higher dose tolerated by differentiated SH-SY5Y neuronal cells, does not provide neuroprotection for terminally differentiated cells and shows, for the first time, that exposure of CBD during neuronal differentiation could sensitize immature cells to future challenges with neurotoxins.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cannabidiol - chemistry</subject><subject>Cannabidiol - pharmacology</subject><subject>Cell Biology</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Line, Tumor</subject><subject>Cell Shape - drug effects</subject><subject>Cells</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Humans</subject><subject>Neurobiology</subject><subject>Neurology</subject><subject>Neurons - cytology</subject><subject>Neurons - drug effects</subject><subject>Neurosciences</subject><subject>Neurotoxicity</subject><subject>Neurotoxins - toxicity</subject><subject>Oxidation-Reduction - drug effects</subject><subject>Tretinoin - pharmacology</subject><issn>0893-7648</issn><issn>1559-1182</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kUtv1DAUhS3Uik5LfwAbFKmbbgy-fsTxcjQtFKmiEtC15SQ3lauMPdhJNeXX41EKQkis7uJ-59zHIeQtsPfAmP6QgTOhKANJm0YKCq_ICpQyFKDhR2TFGiOormVzQk5zfmSMc2D6NTnhClhTa7Yiw8aF4Frf-zhW1_tdzHPC6mpOPjxUX3BOMbixuvLDgAnD5N3kY6i-Ych-8j8xVxscx1ytH5wPeaq-Yh_3dN1N_gkX-RT3pfOGHA9uzHj-Us_I_cfr75sbenv36fNmfUs7JWGiXJoeBR86lI4bIYAN0KtWcIm15ACaA4pWmbJ-z007yAaE7HvsdGdqoZg4I5eL7y7FHzPmyW597sqKLmCcswXNDBjGpSjoxT_oY5xTubZQtdEapDKyULBQXYo5JxzsLvmtS88WmD2EYJcQbAnBHkKwUDTvXpzndov9H8XvrxeAL0DeHf6M6a_R_3X9BSd6kY0</recordid><startdate>20150801</startdate><enddate>20150801</enddate><creator>Schönhofen, Patrícia</creator><creator>de Medeiros, Liana M.</creator><creator>Bristot, Ivi Juliana</creator><creator>Lopes, Fernanda M.</creator><creator>De Bastiani, Marco A.</creator><creator>Kapczinski, Flávio</creator><creator>Crippa, José Alexandre S.</creator><creator>Castro, Mauro Antônio A.</creator><creator>Parsons, Richard B.</creator><creator>Klamt, Fábio</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QR</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20150801</creationdate><title>Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins</title><author>Schönhofen, Patrícia ; de Medeiros, Liana M. ; Bristot, Ivi Juliana ; Lopes, Fernanda M. ; De Bastiani, Marco A. ; Kapczinski, Flávio ; Crippa, José Alexandre S. ; Castro, Mauro Antônio A. ; Parsons, Richard B. ; Klamt, Fábio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-249de32fce4a293310f1d5b324e64211721e3b59510d29bf48134ddec7c963503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cannabidiol - chemistry</topic><topic>Cannabidiol - pharmacology</topic><topic>Cell Biology</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Line, Tumor</topic><topic>Cell Shape - drug effects</topic><topic>Cells</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Humans</topic><topic>Neurobiology</topic><topic>Neurology</topic><topic>Neurons - cytology</topic><topic>Neurons - drug effects</topic><topic>Neurosciences</topic><topic>Neurotoxicity</topic><topic>Neurotoxins - toxicity</topic><topic>Oxidation-Reduction - drug effects</topic><topic>Tretinoin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schönhofen, Patrícia</creatorcontrib><creatorcontrib>de Medeiros, Liana M.</creatorcontrib><creatorcontrib>Bristot, Ivi Juliana</creatorcontrib><creatorcontrib>Lopes, Fernanda M.</creatorcontrib><creatorcontrib>De Bastiani, Marco A.</creatorcontrib><creatorcontrib>Kapczinski, Flávio</creatorcontrib><creatorcontrib>Crippa, José Alexandre S.</creatorcontrib><creatorcontrib>Castro, Mauro Antônio A.</creatorcontrib><creatorcontrib>Parsons, Richard B.</creatorcontrib><creatorcontrib>Klamt, Fábio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest Science Journals</collection><collection>ProQuest Biological Science Journals</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Molecular neurobiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schönhofen, Patrícia</au><au>de Medeiros, Liana M.</au><au>Bristot, Ivi Juliana</au><au>Lopes, Fernanda M.</au><au>De Bastiani, Marco A.</au><au>Kapczinski, Flávio</au><au>Crippa, José Alexandre S.</au><au>Castro, Mauro Antônio A.</au><au>Parsons, Richard B.</au><au>Klamt, Fábio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins</atitle><jtitle>Molecular neurobiology</jtitle><stitle>Mol Neurobiol</stitle><addtitle>Mol Neurobiol</addtitle><date>2015-08-01</date><risdate>2015</risdate><volume>52</volume><issue>1</issue><spage>26</spage><epage>37</epage><pages>26-37</pages><issn>0893-7648</issn><eissn>1559-1182</eissn><abstract>Cannabidiol (CBD), one of the most abundant Cannabis sativa -derived compounds, has been implicated with neuroprotective effect in several human pathologies. Until now, no undesired side effects have been associated with CBD. In this study, we evaluated CBD’s neuroprotective effect in terminal differentiation (mature) and during neuronal differentiation (neuronal developmental toxicity model) of the human neuroblastoma SH-SY5Y cell line. A dose-response curve was performed to establish a sublethal dose of CBD with antioxidant activity (2.5 μM). In terminally differentiated SH-SY5Y cells, incubation with 2.5 μM CBD was unable to protect cells against the neurotoxic effect of glycolaldehyde, methylglyoxal, 6-hydroxydopamine, and hydrogen peroxide (H 2 O 2 ). Moreover, no difference in antioxidant potential and neurite density was observed. When SH-SY5Y cells undergoing neuronal differentiation were exposed to CBD, no differences in antioxidant potential and neurite density were observed. However, CBD potentiated the neurotoxicity induced by all redox-active drugs tested. Our data indicate that 2.5 μM of CBD, the higher dose tolerated by differentiated SH-SY5Y neuronal cells, does not provide neuroprotection for terminally differentiated cells and shows, for the first time, that exposure of CBD during neuronal differentiation could sensitize immature cells to future challenges with neurotoxins.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>25108670</pmid><doi>10.1007/s12035-014-8843-1</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0893-7648
ispartof Molecular neurobiology, 2015-08, Vol.52 (1), p.26-37
issn 0893-7648
1559-1182
language eng
recordid cdi_proquest_miscellaneous_1709190243
source MEDLINE; SpringerLink
subjects Biomedical and Life Sciences
Biomedicine
Cannabidiol - chemistry
Cannabidiol - pharmacology
Cell Biology
Cell Differentiation - drug effects
Cell Line, Tumor
Cell Shape - drug effects
Cells
Gene Expression Regulation - drug effects
Humans
Neurobiology
Neurology
Neurons - cytology
Neurons - drug effects
Neurosciences
Neurotoxicity
Neurotoxins - toxicity
Oxidation-Reduction - drug effects
Tretinoin - pharmacology
title Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T16%3A59%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cannabidiol%20Exposure%20During%20Neuronal%20Differentiation%20Sensitizes%20Cells%20Against%20Redox-Active%20Neurotoxins&rft.jtitle=Molecular%20neurobiology&rft.au=Sch%C3%B6nhofen,%20Patr%C3%ADcia&rft.date=2015-08-01&rft.volume=52&rft.issue=1&rft.spage=26&rft.epage=37&rft.pages=26-37&rft.issn=0893-7648&rft.eissn=1559-1182&rft_id=info:doi/10.1007/s12035-014-8843-1&rft_dat=%3Cproquest_cross%3E1709190243%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1697714594&rft_id=info:pmid/25108670&rfr_iscdi=true